Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgY for prevention of recurrent Pseudomonas aeruginosa infection in cystic fibrosis
2011-000801-39Phase 3Completed
- Sponsor
- Mukoviszidose Institut
- Start
- Apr 2011
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Pseudomonal infection and cystic fibrosis (CF) comparing IgY with Placebo (2 arms). Primary endpoint: Time to first recurrence of Pseudomonas aeruginosa. Started Apr 2011; status: completed.
02
Drugs
avian polyclonal anti-Pseudomonas antibodies (IgY)
03
Conditions
Pseudomonal infectioncystic fibrosis (CF)
Beyond the preview
Go deeper on 2011-000801-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000801-39.